Page 7 - Shared Purpose News Today

Danaher Reports First Quarter 2021 Results News provided by Share this article Share this article WASHINGTON, April 22, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the first quarter 2021.  All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended April 2, 2021, net earnings were $1.7 billion, or $2.29 per diluted common share which represents a 182.5% year-over-year increase from the compara...

Danaher To Present At Cowen Healthcare Conference News provided by Share this article Share this article WASHINGTON, Feb. 22, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Cowen Healthcare Conference on Monday, March 1, 2021 at 11:40 a.m. ET. The video will be simultaneously webcast on www.danaher.com.  ABOUT DANAHER Danaher is a global science and technology innovator committed to helping ...

Danaher CEO To Comment On Financial Performance News provided by Share this article Share this article WASHINGTON, Jan. 13, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment today on the Companys fourth quarter 2020 performance in a presentation at the J.P. Morgan Healthcare Conference at 10:50 a.m. ET. Mr. Blair will communicate that fourth quarter 2020 core revenue growth including Cyt...

Danaher Schedules Fourth Quarter 2020 Earnings Conference Call News provided by Share this article Share this article WASHINGTON, Jan. 7, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2020 on Thursday, January 28, 2021 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danahers website, www.dan...

Danaher Announces Executive Appointment Share this article Share this article WASHINGTON, Dec. 21, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that Jose-Carlos ("JC") Gutierrez-Ramos has been named Senior Vice President and Chief Scientific Officer for Danaher. In this role, Dr. Gutierrez-Ramos will have responsibility for helping define Danahers science and technology strategy across the organization, including facilitating innovation and further development of scient...

Danaher announces leadership appointment Danaher Corporation announced today that effective January 1, 2021 its Board of Directors has appointed Jennifer L. Honeycutt to the position of Executive Vice President of Danaher Corporation, with responsibility for the Company’s Beckman Coulter Life Sciences, Integrated DNA Technologies Leica Microsystems, Molecular Devices, Pall, Phenomenex, and SCIEX businesses. With this appointment, Ms. Honeycutt will become … Danaher Corporation (NYSE: DHR) a...